Amedisys, Inc. Amedisys, Inc.

Amedisys, Inc.

AMED

Hisse Senetlerindeki Sıralama #4614
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Hisse Fiyatı
$100.99
Son senkronizasyon: 2025-08-15
Piyasa Değeri
$3.31B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Amedisys, Inc. (AMED)

Kategori

Healthcare
Amedisys, Inc. (AMED) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 4.03%
Amedisys, Inc. şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 4.03%'dir. 2023 yılı sonunda şirketin faaliyet marjı 6.99% idi.
Amedisys, Inc. için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
Yıl Faaliyet Marjı Değiştir
2026 (TTM) 4.03% 0.00%
2024 4.03% -42.35%
2023 6.99% -14.02%
2022 8.13% -28.56%
2021 11.38% 7.56%
2020 10.58% 16.65%
2019 9.07% -2.79%
2018 9.33% 82.23%
2017 5.12% 28.32%
2016 3.99% -654.17%
2015 -0.72% -136.00%
2014 2.00% -116.13%
2013 -12.40% 64.46%
2012 -7.54% -76.45%
2011 -32.02% -370.44%
2010 11.84% -22.36%
2009 15.25% 15.27%
2008 13.23% -4.41%
2007 13.84% 14.10%
2006 12.13% -7.62%
2005 13.13% -10.68%
2004 14.70% 46.12%
2003 10.06% 100.80%
2002 5.01% -26.00%
2001 6.77% 16,825.00%
2000 0.04% 0.00%
Benzer şirketler veya rakipler için Faaliyet Marjı
Şirket Faaliyet Marjı Faaliyet Marjı Farkı Ülke
15.48% -96.16%
US
0.00% -
DE
16.80% -95.83%
US
18.67% -95.37%
SA
0.00% -
MY
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.